Latest Xarleto news
Diltiazem Linked to Increased Risk for Bleeding Complications in A-Fib
posted March 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
AHA: Rivaroxaban Does Not Top Aspirin After Catheter Ablation for A-Fib
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Six Additional Weeks of Rivaroxaban Reduces Recurrent VTE
posted November 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Rivaroxaban Improves Clinical Outcomes After COVID-19 Hospitalization
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2
New Guideline Details Diagnosis, Treatment of Acute Pulmonary Embolism
Guideline Updated for Early Management of Acute Ischemic Stroke
Risks for Vascular, Inflammatory Diseases Increased for Children After COVID-19
Rivaroxaban Does Not Reduce VTE Incidence in High-Risk Cancer Patients
No Clear Benefit for Rivaroxaban After Hospital Discharge
Rivaroxaban OK for Stroke Prevention in Cancer Patients